Difference between revisions of "Template:Did you know nominations/Azeloprazole"

From blackwiki
Jump to navigation Jump to search
imported>Biochemistry&Love
(DYK nom.)
 
imported>Biochemistry&Love
(Wikilinked)
Line 13: Line 13:
  
 
-->
 
-->
* ... that '''azeloprazole''' was designed with [[pharmacogenomics]] in mind?  <small>Source: "Azeloprazole sodium was synthesized to overcome
+
* ... that '''[[azeloprazole]]''' was designed with [[pharmacogenomics]] in mind?  <small>Source: "Azeloprazole sodium was synthesized to overcome
 
issues associated with the metabolism of marketed PPIs by CYP2C19." (Toda R. et al. ''The Journal of Clinical Pharmacology''. 2017;00(0):1–9. DOI:10.1002/jcph.1038.)</small>
 
issues associated with the metabolism of marketed PPIs by CYP2C19." (Toda R. et al. ''The Journal of Clinical Pharmacology''. 2017;00(0):1–9. DOI:10.1002/jcph.1038.)</small>
 
:*
 
:*

Revision as of 06:07, 26 December 2017

Azeloprazole

A three-dimensional representation of zeloprazole spinning along an axis.
A three-dimensional representation of zeloprazole spinning along an axis.

issues associated with the metabolism of marketed PPIs by CYP2C19." (Toda R. et al. The Journal of Clinical Pharmacology. 2017;00(0):1–9. DOI:10.1002/jcph.1038.)

  • Comment: Moved from sandbox. About 1900 characters. Using DYK credit from Dominique Blake.

Created by Biochemistry&Love (talk). Self-nominated at 06:02, 26 December 2017 (UTC).